Key result
Study evaluates prescribed controlled substance utilization trends among commercially insured US adults from 2004 to 2019.
The study provides an overview of the utilization trends of prescribed controlled substances among commercially insured adults in the US from 2004 to 2019.
Answers are grounded in this paper and cite their sources.
Maps 15-year controlled substance trends; leaves open causal links and practice implications from observational data.
This study examines the most commonly dispensed categories and individual substances of all prescribed controlled substances, including stimulants, benzodiazepines, and depressants, among US commercially insured adults.
No takes yet. Share an insight, caveat, or question.
Bykov et al. (2020) studied this question. Prescribed controlled substances, including stimulants, benzodiazepines, and depressants, were evaluated for utilization trends among US commercially insured adults from 2004 to 2019.
Synapse has enriched 10 related papers. Consider them for comparative context: